Expression of Metalloproteinases and Their Inhibitors in Blood Vesselsin Human Endometrium1
- 1 October 1999
- journal article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 61 (4) , 1070-1082
- https://doi.org/10.1095/biolreprod61.4.1070
Abstract
Matrix metalloproteinases (MMPs) are zinc-requiring enzymes that can degrade components of the extracellular matrix and that are implicated in tissue remodeling. Their role in the onset of menstruation in vivo has been proven; however, the expression and functions of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in vascular structures are poorly understood. We determined by immunocytochemistry, using characterized monoclonal antibodies, the distribution of MMPs and of their inhibitors TIMP-1 and TIMP-2 in the endometrium during the menstrual cycle. MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 had differing distributions and patterns of expression. In addition to the localization of MMP-9 in the epithelium and of MMP-2, MMP-3, and MMP-1 in the stromal tissue, these MMPs were detected in the vascular structures. MMP-2 (72-kDa gelatinase) and tissue inhibitors TIMP-1 and TIMP-2 were detectable in vessels throughout the cycle. In contrast, MMP-3 (stromelysin-1) was detected only in late-secretory and menstrual endometrial vessels, while MMP-9 (92-kDa gelatinase) was detected in spiral arteries during the secretory phase and in vascular structures during the midfollicular and menstrual phases. The expression of MMP-2 and MMP-9 in endometrial vessels during the proliferative and secretory periods suggests their relationship to vascular growth and angiogenesis. The pronounced expression of MMP-3 (stromelysin-1) in the vessels situated in the superficial endometrial layer during menses suggests that this metalloproteinase initiates damage in the vascular wall during menstrual breakdown. The finding of an intense expression of TIMP-1 and TIMP-2 in the vessels delineating necrotic from non-necrotic areas during menses also suggests that they could limit tissue damage, allowing regeneration of the endometrium after menses. These data indicate that, in addition to expression in epithelial cells and stromal tissue, MMPs are expressed in endometrial vascular cells in a cycle-specific pattern, consistent with regulation by steroid hormones and with specific roles in the vascular remodeling processes occurring in the endometrium during the cycle.Keywords
This publication has 44 references indexed in Scilit:
- Matrix metalloproteinases in normal menstruationHuman Reproduction, 1996
- Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle.Journal of Clinical Investigation, 1996
- Matrix metalloproteinases and their tissue inhibitors in endocrinologyTrends in Endocrinology & Metabolism, 1996
- Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium.Proceedings of the National Academy of Sciences, 1994
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993
- Ultrastructure of the microvasculature in the human endometrium throughout the normal menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1992
- Microarchitecture of the Human Endometrium by Scanning Electron Microscopy: Menstrual Desquamation and RemodelingAnnals of the New York Academy of Sciences, 1991
- Mechanisms of endometrial bleedingReproduction, Fertility and Development, 1990
- Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.Proceedings of the National Academy of Sciences, 1989
- Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effectsFertility and Sterility, 1983